Cargando…

Health-related quality of life as an endpoint in oncology phase I trials: a systematic review

BACKGROUND: Phase I trials aim to identify the recommended dose for further development. Health-related quality of life (HRQoL) could be a complement to the usual National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) scale to detect adverse events and define the doses....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiteni, Frédéric, Ray, Isabelle Le, Ousmen, Ahmad, Isambert, Nicolas, Anota, Amélie, Bonnetain, Franck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469065/ https://www.ncbi.nlm.nih.gov/pubmed/30991990 http://dx.doi.org/10.1186/s12885-019-5579-3

Ejemplares similares

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?
por: Anota, Amélie, et al.
Publicado: (2013)

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
por: Ousmen, Ahmad, et al.
Publicado: (2018)

Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time
por: Ousmen, Ahmad, et al.
Publicado: (2016)

Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study
por: Anota, Amélie, et al.
Publicado: (2014)

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists
por: Methy, Nicolas, et al.
Publicado: (2010)

Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial
por: Rotonda, Christine, et al.
Publicado: (2015)

An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma
por: Anota, Amélie, et al.
Publicado: (2016)

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial
por: Anota, Amélie, et al.
Publicado: (2015)

Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients
por: Anota, Amélie, et al.
Publicado: (2014)

Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol
por: Deliu, Nina, et al.
Publicado: (2018)

A longitudinal analysis of patient satisfaction with care and quality of life in ambulatory oncology based on the OUT-PATSAT35 questionnaire
por: Nguyen, Thanh Vân France, et al.
Publicado: (2014)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol
por: Mouillet, Guillaume, et al.
Publicado: (2019)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma
por: Paquette, Brice, et al.
Publicado: (2016)

The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas
por: Kim, Stefano, et al.
Publicado: (2015)

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
por: Fiteni, Frédéric, et al.
Publicado: (2014)

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
por: Charton, Emilie, et al.
Publicado: (2019)

Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
por: Ang, Joo Ern, et al.
Publicado: (2012)

Quality of Life in Low-Risk MDS: An Undervalued Endpoint
por: Heyrman, Bert
Publicado: (2022)

Health-Related Quality of Life of Lebanese Women With Breast Cancer: Protocol for a Prospective Cohort Study
por: El Haidari, Rana, et al.
Publicado: (2021)

Factors Associated with Health-Related Quality of Life in Women with Breast Cancer in the Middle East: A Systematic Review
por: El Haidari, Rana, et al.
Publicado: (2020)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Analysis of composite endpoints in gene expression studies in oncology
por: Marhoon, ZA, et al.
Publicado: (2015)

Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment
por: Calviño-Suárez, Cristina, et al.
Publicado: (2021)

Erratum to: Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty
por: Vernerey, Dewi, et al.
Publicado: (2016)

Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty
por: Vernerey, Dewi, et al.
Publicado: (2016)

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
por: Fiteni, Frédéric, et al.
Publicado: (2014)

Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)
por: Lamy, Simon, et al.
Publicado: (2023)

Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)
por: Servagi-Vernat, Stéphanie, et al.
Publicado: (2017)

Pre-operative and early postoperative health-related quality of life of breast cancer woman: a Lebanese prospective study
por: El Haidari, Rana, et al.
Publicado: (2023)

A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials
por: Cabarrou, Bastien, et al.
Publicado: (2022)

Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology
por: Sherrill, Beth, et al.
Publicado: (2012)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
por: Blumenthal, Gideon M., et al.
Publicado: (2017)

Challenges in translating endpoints from trials to observational cohort studies in oncology
por: Ording, Anne Gulbech, et al.
Publicado: (2016)

Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage
por: Isaacs, James, et al.
Publicado: (2022)

Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
por: Fumoleau, Pierre, et al.
Publicado: (2013)

Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial
por: Pozet, Astrid, et al.
Publicado: (2016)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qf8q6240l3pftfqi0leivgcv1l